One study reported that miR-550a-3p was reduced in breast cancer and was associated with inhibition of disease development.[39] In this study, ERK1 and ERK2 were confirmed to be the target genes of miR-550a-3p. This evidence concerns the gene MAPK1 and breast cancer.